A progressive think tank has circulated a detailed 181-182 page blueprint urging Democratic lawmakers to investigate Coinbase CEO Brian Armstrong and World Liberty Financial, a crypto firm partly owned by the Trump family. The document highlights potential favoritism and policy influence tied to Trump, placing these crypto entities alongside major companies like Tesla and Apple for scrutiny. Coinbase's recent US trust charter approval and World Liberty's token buyback program have drawn particular attention. The investigations could impact market confidence and regulatory approaches ahead of the midterm elections.
The oversight blueprint naming Coinbase CEO Brian Armstrong and World Liberty Financial comes as a backdrop to market movements in major cryptocurrencies. For readers following cryptocurrency markets, here is Pluang's snapshot as of Nov 14, 2026 01:41 WIB: out of 50 major cryptocurrencies, 22 rose and 27 fell today. Notable movers include SXP (Solar) down 46.27% at Rp37 with a typical hold time of 94 days, BAL (Balancer) up 11.14% at Rp16,297 with a typical hold time of 85 days, and EOS (EOS.IO) up 8.13% at Rp12,649 with a typical hold time of 87 days.
Susan R. Burns, Ph.D., President of the University of Mount Saint Vincent, has been awarded the 2027 Courageous Leadership Award for her visionary and bold leadership. Since 2021, she has led the university through significant transformation, includi...
Solo, a company specializing in privacy-preserving human verification, has integrated its SDK into JellyJelly, a social video app co-founded by Venmo's co-founder. This integration ensures that every JellyJelly account belongs to a real, unique perso...
The U.S. market for AI-enabled ophthalmic diagnostic devices is projected to grow from $72.5 million in 2026 to $267.2 million by 2033, expanding at a 20.5% CAGR. Growth is driven by rising diabetes-related eye diseases, FDA clearances for autonomous...
The global medical display monitors market, valued at $2.8 billion in 2025, is projected to grow to $4.0 billion by 2033 with a CAGR of 4.6%. Growth is fueled by rising adoption of digital imaging systems, demand for accurate diagnostics, and healthc...
Oppenheimer downgraded Enovix from Outperform to Perform as the company expands production in South Korea and shifts focus to drone and smart-eyewear customers. Enovix reported a 38% revenue increase to $11 million in Q3 but saw its adjusted loss wid...
